KR100294621B1 - Manufacturing method of Iopamidol - Google Patents

Manufacturing method of Iopamidol Download PDF

Info

Publication number
KR100294621B1
KR100294621B1 KR1019980022514A KR19980022514A KR100294621B1 KR 100294621 B1 KR100294621 B1 KR 100294621B1 KR 1019980022514 A KR1019980022514 A KR 1019980022514A KR 19980022514 A KR19980022514 A KR 19980022514A KR 100294621 B1 KR100294621 B1 KR 100294621B1
Authority
KR
South Korea
Prior art keywords
acid
acid chloride
formula
chloride
iopamidol
Prior art date
Application number
KR1019980022514A
Other languages
Korean (ko)
Other versions
KR20000001987A (en
Inventor
심상철
최흥진
이동엽
이인규
최경석
박진규
Original Assignee
강재헌
동국제약 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 강재헌, 동국제약 주식회사 filed Critical 강재헌
Priority to KR1019980022514A priority Critical patent/KR100294621B1/en
Publication of KR20000001987A publication Critical patent/KR20000001987A/en
Application granted granted Critical
Publication of KR100294621B1 publication Critical patent/KR100294621B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/22Separation; Purification; Stabilisation; Use of additives
    • C07C231/24Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring

Abstract

본 발명은 명세서중의 반응식 1에 따라 화학식 1의 이오파미돌을 제조함에 있어서, 화학식 6의 5-아미노이소프탈산과 KICl2를 반응시키는 공정 1을 촉매량의 요오드 존재하에 수행하고 공정 3에서는 락트산에 톨루엔을 가하여 공비증류로 물을 제거한 다음 아세트산무수물과 초산 및 티오닐클로라이드를 반응시켜 제조된 0-아세틸락트산클로라이드와 화학식 4의 5-아미노-2,4,6-트리요오도이소프탈산클로라이드를 반응시킴을 특징으로 하는 방법에 관한 것이다.In the present invention, in preparing iopamidol of Chemical Formula 1 according to Scheme 1, Step 1 of reacting 5-aminoisophthalic acid of Chemical Formula 6 with KICl 2 in the presence of a catalytic amount of iodine is carried out in lactic acid. Toluene was added to remove water by azeotropic distillation, and then 0-acetyllactic acid chloride prepared by reacting acetic anhydride with acetic acid and thionyl chloride was reacted with 5-amino-2,4,6-triiodoisophthalic acid chloride of the formula (4). It relates to a method characterized by sikkim.

Description

이오파미돌의 제조방법How to prepare Iopamidol

본 발명은 이오파미돌의 개량된 제조방법에 관한 것이다.The present invention relates to an improved method for preparing iopamidol.

X-ray 조영제로서 널리 사용되고 있는 이오파미돌의 공지된 제조방법으로는 L-5-(2-아세톡시프로피오닐아미노)-2,4,6-트리요오도이소프탈산할라이드와 2-아미노-1,3-프로판디올("세리놀")을 염기성 물질 존재하에 디메틸아세트아미드 용매중에서 아미드화반응시켜 제조하는 스위스 Savac A.G.사의 방법(B.P.1,472,050)이 알려져 있고, 기타 이오파미돌의 정제방법이나 제조중간체인 5-아미노-2,4,6-트리요오도이소프탈산의 합성법에 대한 연구가 활발히 진행되어 왔다.Known methods for preparing iopamidol, which are widely used as X-ray contrast agents, include L-5- (2-acetoxypropionylamino) -2,4,6-triiodoisophthalic acid halide and 2-amino-1 The method of Savac AG, Switzerland (BP1,472,050), which is prepared by amidation of, 3-propanediol ("serinol") in a dimethylacetamide solvent in the presence of a basic substance, is known. Studies on the synthesis of phosphorus 5-amino-2,4,6-triiodoisophthalic acid have been actively conducted.

그러나, 이러한 공지방법들은 제조과정에서 여러번의 여과와 건조공정이 요구될 뿐아니라 반응부산물인 요오드로 인한 공해문제가 심각하게 대두되어 왔으며, 그런 복잡한 과정으로 인한 수율의 저하를 초래하였다.However, these known methods not only require several filtration and drying processes in the manufacturing process, but also have caused serious pollution problems due to reaction by-products of iodine, resulting in lowered yields due to such complex processes.

이에, 본 발명자들은 위와 같은 공지방법들을 단계별로 나누어 각 공정의 반응조건을 여러가지로 변화시키며 비교연구하였으며, 그 결과 혁신적인 공정의 단순화와 수율의 향상을 확인하고 본 발명을 완성하게 되었다.Thus, the present inventors divided the above known methods into stages and compared and studied the reaction conditions of each process in various ways. As a result, the present invention confirmed the simplification of the innovative process and the improvement of the yield and completed the present invention.

하기 화학식 1의 이오파미돌의 공지된 제조방법으로서 대표적인 방법은 하기 반응식 1과 같이 나타낼 수 있다.As a known method for preparing iopamidol represented by Chemical Formula 1, a representative method may be represented by the following Scheme 1.

그런데, 상기 반응식 1에 따른 제조방법에서 화학식 6의 화합물에 KICl2를 반응시켜 화학식 5의 화합물을 제조하는 제 1 공정의 요오드화 반응은 하기 반응식 2에 따라 제조되는 KICl2를 사용하게 되는데, 이중 이염화요오드 음이온이 하기 반응식 3과 같은 평형상태를 이루게되어 반응계에 요오드가 생성되어 유리됨으로써 이염화요오도의 유효농도가 감소하게 된다.However, in the preparation method according to Scheme 1, the iodide reaction of the first step of preparing the compound of Formula 5 by reacting KICl 2 with the compound of Formula 6 uses KICl 2 prepared according to Scheme 2 below. Since the iodine anion is in an equilibrium state as in Scheme 3, iodine is generated and released in the reaction system, thereby reducing the effective concentration of iodine dichloride.

이러한 현상을 방지하기 위하여 반응액중에 과량의 HCl을 가하면 평형이 왼쪽으로 치우쳐 이염화요오드 음이온의 농도는 증가시킬 수 있는 반면, 과도한 산의 존재로 인하여 방향족 친전자 치환반응의 반응기질인 5-아미노이소프탈산이 양성화되어 반응성이 떨어지게 된다. 따라서, 본 발명자들은 반응액중의 이염화요오드 이온 농도를 적절히 유지시킬 수 있는 방법을 개발하고자 노력하였으며, 그 결과 반응계내에 촉매량의 I2를 첨가하면 이러한 목적을 달성할 수 있고, 결국 화학식 6의 화합물로부터 용이하게 화학식 5의 화합물로 요오드화 반응을 수행할 수 있음을 발견하였다.To prevent this phenomenon, the addition of excess HCl to the reaction liquid can cause the equilibrium to be shifted to the left, increasing the concentration of iodine dichloride anion, whereas 5-amino, which is a reactive group of aromatic electrophilic substitution reaction due to the presence of excessive acid. Isophthalic acid is protonated, resulting in poor reactivity. Therefore, the present inventors have tried to develop a method capable of properly maintaining the concentration of iodine dichloride ion in the reaction solution, and as a result, the addition of a catalytic amount of I 2 in the reaction system can achieve this purpose. It has been found that the iodide reaction can be easily carried out from the compound with the compound of formula 5.

이와 같이 촉매량의 요오드를 첨가하는 경우 화학식 5 화합물의 수율을 종래 85%에서 96% 이상으로 상승시킬 수 있으며, 이러한 수율의 향상은 쉽게 예상하기 어려웠던 것이다. 따라서, 본 발명의 특징은 출발화합물(6)에 KICl2와 함께 촉매량의 I2를 첨가함으로써 화학식 5 화합물의 수율을 향상시킨 점에 있다.As such, when the catalytic amount of iodine is added, the yield of the compound of Formula 5 may be increased from 85% to 96% or more, and the improvement of the yield is difficult to predict easily. Therefore, a feature of the present invention is that the yield of the compound of formula (5) is improved by adding a catalytic amount of I 2 to the starting compound (6) together with KICl 2 .

본 발명의 또다른 특징은 상기 반응식 1에 따른 공지의 제조방법에서 제조공정 3의 개량에 있다. 즉, 화학식 4의 화합물인 5-아미노-2,4,6-트리요오도이소프탈산클로라이드를 0-아세틸락트산클로라이드로 아미드화 반응을 시키는 경우 라세미화가 일어날 가능성이 크고 특히 염기촉매를 사용하는 경우 이 라세미화는 가속화된다. 라세미화에 의해 생성된 에난쇼오머로 인하여 최종 화합물의 광학활성이나 생화학적 활성 및 물에 대한 용해도와 같은 물리적 특성에 영향을 미치게 되므로 라세미화를 최소화하기 위해서는 삼급아민의 사용을 억제하여야 하는데 그 경우 반응성이 저하되어 수율의 저하를 피할 수 없게 된다.Another feature of the present invention lies in the improvement of the manufacturing process 3 in the known production method according to Scheme 1. That is, when amidation of 5-amino-2,4,6-triiodoisophthalic acid chloride, a compound of Formula 4, with 0-acetyllactic acid chloride, there is a high possibility that racemization occurs, especially when a base catalyst is used. This racemization is accelerated. Enantiomers produced by racemization affect physical properties such as optical activity, biochemical activity, and solubility in water of the final compound. Therefore, the use of tertiary amines should be suppressed to minimize racemization. This lowers and the yield decreases cannot be avoided.

이에, 본 발명자들은 이러한 문제를 해결하기 위하여 삼급아민을 사용하지 않고도 반응성이 유지될 수 있는 반응물질을 개발하고자 연구하던 중 과량의 톨루엔에 용해되어 있는 0-아세틸락트산클로라이드를 사용하여 실온에서 충분한 시간동안 반응시키면 반응을 완결시킬 수 있음을 확인하게 되었다. 과량의 톨루엔에 용해되어 있는 0-아세틸락트산클로라이드는 하기 반응식 4에 따라 제조할 수 있다.In order to solve this problem, the inventors of the present invention, while studying to develop a reactant that can be maintained without the use of a tertiary amine, sufficient time at room temperature using 0-acetyl lactic acid chloride dissolved in excess toluene It was confirmed that the reaction can be completed by the reaction. 0-acetyllactic acid chloride dissolved in excess toluene can be prepared according to Scheme 4 below.

즉, 출발물질인 락트산에는 약 8%의 물이 포함되어 있는데, 이와 같이 물이 소량 존재함으로써 아세틸화 수율이 낮다. 따라서, 본 발명자들은 락트산중의 물을 제거하면서 아세틸화시키는 방법을 강구하고자 노력하였으며, 이러한 노력의 결과로 락트산을 톨루엔중에서 공비증류시켜 물을 제거하고 아세트산무수물 및 초산을 가하여 반응시킨 다음, 증류를 통해 초산을 제거하고 티오닐클로라이드를 가하여 반응시키면 0-아세틸락틸클로라이드를 제조함에 있어서 종전의 50%에서 80% 이상으로 수율을 상승시킬 수 있다는 놀라운 사실을 발견하였다. 더구나, 종전에는 수율이 50% 정도로 저조하였기 때문에 제조된 0-아세틸락트산클로라이드를 진공분별증류에 의해 일단 분리한 후 다음 반응에 사용하여야 했지만 본 발명에 따른 방법에서는 충분히 수율이 높아졌으므로 별도의 분리공정없이 톨루엔에 용해되어 있는 상태로 직접 다음 공정을 수행할 수 있게 되었다. 본 발명에 따른 공정 3에서 상기 방법에 따라 제조된 0-아세틸락트산클로라이드는 화학식 4의 5-아미노-2,4,6-트리요오도이소프탈산클로라이드에 대해 1.5 내지 1.8 당량배로 사용하는 것이 바람직하다. 또한, 이렇게 하여 수득된 화학식 3의 화합물은 의외로 물에 대해 안정하므로 물을 이용하여 분리, 정제하는 것이 가능하다.That is, the starting material lactic acid contains about 8% of water, the low amount of acetylation by the presence of a small amount of water in this way. Therefore, the present inventors have tried to devise a method of acetylation while removing water in lactic acid, and as a result of this effort, lactic acid was azeotropically distilled in toluene to remove water, reacted with acetic anhydride and acetic acid, and then distilled It was surprisingly found that removal of acetic acid and reaction with thionyl chloride can increase the yield from 50% to over 80% in preparing 0-acetyllactyl chloride. Moreover, in the past, since the yield was low at about 50%, the prepared 0-acetyllactic acid chloride had to be separated once by vacuum fractional distillation and then used in the next reaction. It is now possible to carry out the next process directly without being dissolved in toluene. In the process 3 according to the present invention, 0-acetyllactic acid chloride prepared according to the above method is preferably used in an amount of 1.5 to 1.8 equivalents based on 5-amino-2,4,6-triiodoisophthalic acid chloride of the formula (4). . In addition, the compound of the formula (3) thus obtained is surprisingly stable against water, and thus it is possible to separate and purify using water.

따라서, 본 발명은 상기 반응식 1에 따라 화학식 1의 이오파미돌을 제조함에 있어서, 화학식 6의 5-아미노이소프탈산과 KICl2를 반응시키는 공정 1을 촉매량의 요오드 존재하에 수행하고 공정 3에서는 락트산에 톨루엔을 가하여 공비증류로 물을 제거한 다음 아세트산무수물과 초산 및 티오닐클로라이드를 반응시켜 제조된 0-아세틸락트산클로라이드와 화학식 4의 5-아미노-2,4,6-트리요오도이소프탈산클로라이드를 반응시킴을 특징으로 하는 방법을 제공함을 목적으로 한다. 특히, 본 발명의 바람직한 일실시예에 의하면, 상기 공정 1에서 투입되는 요오드의 촉매량은 구체적으로 5-아미노이소프탈산 대비 1 내지 5중량%인 것이 바람직하다.Accordingly, the present invention is to prepare the iopamidol of the formula (1) according to Scheme 1, the step 1 of reacting 5-aminoisophthalic acid of formula 6 and KICl 2 in the presence of a catalytic amount of iodine and in the step 3 to lactic acid Toluene was added to remove water by azeotropic distillation, and then 0-acetyllactic acid chloride prepared by reacting acetic anhydride with acetic acid and thionyl chloride was reacted with 5-amino-2,4,6-triiodoisophthalic acid chloride of the formula (4). It is an object of the present invention to provide a method characterized by the use of the system. In particular, according to a preferred embodiment of the present invention, the amount of iodine added in step 1 is preferably 1 to 5% by weight relative to 5-aminoisophthalic acid.

상기 본 발명에 따른 특징적인 공정 이외에 기타 공정들은 공지의 방법에 따라 수행할 수 있는데, 예를들어 공정 2는 화학식 5의 5-아미노-2,4,6-트리요오도이소프탈산을 티오닐클로라이드와 반응시켜 산할라이드를 제조하는 과정으로서, 합성상의 난점은 없으나 산업화에 따른 폐기물의 처리나 환경유해 기체의 배출을 최소화하는 방법으로 최소량의 티오닐클로라이드를 사용하는 반응조건이 필요하다. 공정 2의 반응은 용매없이 과량의 티오닐클로라이드만을 사용하거나, 반응용매로서 DMF, DMA, 에틸아세테이트 등의 용매를 사용하는 경우가 있는데, 본 발명에서는 최소량의 티오닐클로라이드를 사용하면서 보다 값이 싸고 재사용이 용이한 에틸아세테이트를 용매로 사용하는 반응조건을 확립하였다. 또한, 이 용매를 생성물의 재결정화에 사용함으로써 95%의 우수한 회수율로 재결정할 수 있었다.Other processes in addition to the characteristic process according to the present invention can be carried out according to a known method, for example, process 2 is a 5-yl-2,4,6-triiodoisophthalic acid of the formula (5) thionyl chloride It is a process of preparing acid halide by reacting with, and there is no difficulty in synthesis, but it requires reaction conditions that use a minimum amount of thionyl chloride as a method of minimizing the discharge of environmentally harmful gases or treatment of waste due to industrialization. The reaction of step 2 may use only an excess of thionyl chloride without a solvent or a solvent such as DMF, DMA, ethyl acetate, etc. as a reaction solvent, but in the present invention, it is cheaper while using a minimum amount of thionyl chloride. Reaction conditions using ethyl acetate as a solvent were established. In addition, by using this solvent for recrystallization of the product, it was possible to recrystallize with an excellent recovery rate of 95%.

공정 4에서는 이오파미돌의 전구체인 화학식 2의 N,N'-비스[2-하이드록시-1-(하이드록시메틸)에틸]-2,4,6-트리요오도-5-(0-아세틸-(S)-락타미도)이소프탈아미드를 합성하기 위하여 공정 3에서 생성된 화학식 3의 화합물을 세리놀과 반응시키게 된다. 세리놀은 물분자보다 친핵성이 큰 일차아민이며 반응시간을 충분히 함으로써 반응을 완결시킬 수 있다. 또한, 기존에는 반응진행중에 생성되는 HCl을 포획 하기 위해 염기로서 트리에틸아민을 사용하여 왔으나, 본 발명에서는 2,6-루티딘을 염기로 사용하였으며 이에 따라 트리에틸아민으로 인한 소량의 부반응을 방지함으로써 고순도로 이오파미돌 전구체를 수득할 수 있었다.In step 4, N, N'-bis [2-hydroxy-1- (hydroxymethyl) ethyl] -2,4,6-triiodo-5- (0-acetyl of the formula (2) which is a precursor of iopamidol In order to synthesize-(S) -lactamido) isophthalamide, the compound of formula 3 produced in step 3 is reacted with cerinol. Serinol is a primary amine with greater nucleophilicity than water molecules and can be completed by allowing sufficient reaction time. In addition, in the past, triethylamine was used as a base to capture HCl generated during the reaction, but in the present invention, 2,6-lutidine was used as a base, thereby preventing a small amount of side reactions caused by triethylamine. By doing this, the iopamidol precursor could be obtained with high purity.

공정 5에서 에스테르 결합의 가수분해는 산 또는 염기 존재하에 쉽게 수행할 수 있으며, 본 발명에서는 반응중에 부산물로서 생성되는 여러 친수성 무기염들의 제거를 고려하여 수산화칼슘을 염기로 사용함으로써 가수분해공정올 수행하였다. 즉, 반응이 완결된 후 반응액중에 황산을 가하면 칼슘이온은 대체로 수용성이 작은 황산칼슘으로 석출되므로 분리가 용이하다.In step 5, the hydrolysis of the ester bond can be easily carried out in the presence of an acid or a base, and in the present invention, the hydrolysis step was performed by using calcium hydroxide as a base in consideration of the removal of various hydrophilic inorganic salts produced as by-products during the reaction. . That is, when sulfuric acid is added to the reaction solution after the reaction is completed, calcium ions are precipitated as calcium sulfate, which is generally small in water solubility.

반응이 완료된 후, 목적하는 이오파미돌을 순수한 상태로 수득하기 위하여 여러 가지 분리정제방법을 수행할 수 있다. 예를들어, 반응혼합물에 잔류된 아민류 불순물은 산성조건에서 암모늄양이온으로 존재하므로 양이온교환수지로 처리하여 유기아민 및 무기양이온올 제거하고, 음이온교환수지로 처리하여 음이온불순물들을 제거함으로써 대체로 순수한 이오파미돌을 얻을 수 있다. 또한, 에탄올에서 재결정을 수행함으로써 결정성 이오파미돌을 얻을 수 있다.After the reaction is completed, various separation and purification methods can be performed to obtain the desired iopamidol in its pure state. For example, the amine impurities remaining in the reaction mixture exist as ammonium cations under acidic conditions, so they are treated with cation exchange resins to remove organic amines and inorganic cations, and anion exchange resins to remove anion impurities. You can get a stone. In addition, crystalline iopamidol can be obtained by performing recrystallization in ethanol.

이하, 본 발명을 하기 실시예에 의거하여 보다 구체적으로 설명한다. 그러나, 이들 실시예는 본 발명에 대한 이해를 돕기위한 것일 뿐, 어떤 의미로든 본 발명의 범위가 이들 실시예로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail based on the following examples. However, these examples are only for the understanding of the present invention, and the scope of the present invention in any sense is not limited to these examples.

[실시예 1] 이염화요오드칼륨 용액(2.1M KICl2solution)의 합성Example 1 Synthesis of Potassium Iodide Dichloride Solution (2.1M KICl 2 solution)

요오드산 칼륨 75.Og(0.35mol), 염화칼륨 42.Og(0.56 mol ), 촉매량의 요오드 1g 및 물 9O㎖의 혼합액에 진한염산 1O㎖(0.1mol)를 가하고 잘 교반하여 백색의 분산혼합액을 제조하였다. 이 분산액을 기계식 교반기로 격렬하게 교반하면서 요오드화칼륨 116.6g(0.07mol)을 물 100㎖에 녹인 수용액과 진한염산(conc. HCl, 180㎖, 1.8mol)을 동시에 천천히 가하면 엷은 노란색의 분산액으로 되면서 점차 진한 노란색의 용액으로 되었다. 이때 요오드화칼륨 용액은 검은색의 요오드가 생성되지 않도록하는 정도의 속도로 가하며 약 1-2 시간이 소요된다. 혼합물을 계속해서 교반하여 진한 검붉은색의 용액을 제조하고 상온에서 30분 정도 더 교반한 후 전체용액의 부피가 500㎖로 되도록 물을 가하여 2.1M 이염화요오드칼륨(KlCl2) 용액을 수득하였다.100 ml of concentrated hydrochloric acid (0.1 mol) was added to a mixture of 75.Og (0.35 mol) of potassium iodide, 42.Og (0.56 mol) of potassium chloride, 1 g of catalytic amount of iodine and 9O ml of water, and stirred well to prepare a white dispersion mixture. It was. The mixture was vigorously stirred with a mechanical stirrer and slowly added an aqueous solution of 116.6 g (0.07 mol) of potassium iodide in 100 ml of water and concentrated hydrochloric acid (conc. HCl, 180 ml, 1.8 mol) simultaneously to form a pale yellow dispersion. It became a dark yellow solution. At this time, potassium iodide solution is added at a speed such that black iodine is not produced, and takes about 1-2 hours. The mixture was continuously stirred to prepare a dark red solution. After stirring for 30 minutes at room temperature, water was added so that the volume of the total solution was 500 ml to obtain 2.1 M potassium iodide dichloride (KlCl 2 ) solution. .

[실시예 2] 5-아미노-2,4,6-트리요오도이소프탈산의 합성Example 2 Synthesis of 5-amino-2,4,6-triiodoisophthalic acid

물 1,250㎖에 5-아미노이소프탈산 30.84g(0.16mol)을 분산시켜 연한 황토색의 분산액을 제조하였다. 여기에 촉매량의 요오드(1g)를 가한 다음 가열하여 60℃로 유지하였다. 이 분산액에 실시예 1에서 수득한 이염화요오드칼륨 용액 250㎖(2.1M)를 1시간에 걸쳐 적하하고 60℃에서 18시간동안 반응시켰다. 생성된 엷은 갈색의 분산액을 상온으로 냉각시키고 다시 빙욕에서 냉각시킨 후 여과하였다. 젖은 고체생성물을 더이상의 여액이 흘러나오지 않을 때까지 공기건조시킨 후, 수산화칼륨 수용액(0.66M, 300㎖)에 용해시켰다. 여기에 활성탄을 3.Og 가하고 pH를 7.0으로 내린 후 탈색하여 여과하고 물(2O㎖×2)로 활성탄을 세척하였다. 여액을 격렬하게 교반하면서 진한 염산을 천천히 가하여 분산액을 제조하고 pH를 1.0-2.0으로 조절하였다. 혼합물을 0-5℃에서 냉각시킨 후 여과하고 얻어진 고체를 60℃에서 진공건조시켜 엷은 갈색의 고체상 표제화합물 86.Og(수율 96%)을 수득하였다.30.84 g (0.16 mol) of 5-aminoisophthalic acid was dispersed in 1,250 ml of water to prepare a light yellow dispersion. A catalytic amount of iodine (1 g) was added thereto, followed by heating to maintain 60 ° C. 250 ml (2.1 M) of potassium iodide dichloride solution obtained in Example 1 was added dropwise to this dispersion over 1 hour, and reacted at 60 degreeC for 18 hours. The resulting pale brown dispersion was cooled to room temperature, again cooled in an ice bath and filtered. The wet solid product was air dried until no more filtrate flowed out and then dissolved in aqueous potassium hydroxide solution (0.66 M, 300 mL). 3.Og of activated carbon was added thereto, the pH was lowered to 7.0, decolorized, filtered, and the activated carbon was washed with water (20 mL × 2). The filtrate was added slowly with concentrated hydrochloric acid while stirring vigorously to prepare a dispersion and the pH was adjusted to 1.0-2.0. The mixture was cooled at 0-5 [deg.] C., filtered and the resulting solid was dried in vacuo at 60 [deg.] C. to give 86.Og (96% yield) of a light brown solid title compound.

13C NMR(75㎒, DMSO) δ 170.3, 150.5, 147.4, 77.4, 70.7 13 C NMR (75 MHz, DMSO) δ 170.3, 150.5, 147.4, 77.4, 70.7

[실시예 3] 5-아미노-2,4,6-트리요오도이소프탈산 클로라이드의 합성Example 3 Synthesis of 5-amino-2,4,6-triiodoisophthalic acid chloride

실시예 2에서 수득한 5-아미노-2,4,6-트리요오도이소프탈산 65.O1g(0.116mol)을 에틸아세테이트 420㎖에 분산시켰다. 분산액에 티오닐클로라이드 55.2g(0.46mol)을 천천히 가하고 생성된 혼합액을 3-4시간동안 가열환류시킨 후 상온으로 냉각시켰다. 과잉의 티오닐클로라이드와 용매를 증류로 제거하고, 증류 잔류물에 에틸아세테이트 135㎖를 가한 다음 다시 감압증류하여 휘발성분을 완전히 제거하였다. 증발 잔류물에 에틸아세테이트 940㎖를 가하여 녹인 후 포화 중탄산나트륨 수용액 1.12ℓ로 세척하고 다시 포화 중탄산나트륨 수용액 0.6ℓ로 세척한 후 유기층을 분리하였다. 분리된 유기층을 무수 탄산칼륨-무수 황산마그네슘(1:1, w/w) 혼합건조제 2O g으로 건조시키고 여과하여 투명한 여액을 얻었다. 여액중의 용매를 감압(730 ㎜Hg)하에 천천히 증발시키면서 결정화한 후 여과하고 수득된 결정을 약 2Og의 n-헥산으로 세척하였다. 50℃에서 진공건조시켜 일차생성물(52.4g, 수율 80%)를 얻었다. 전단계에서 수득한 여액에 대해 다시 상기 과정을 되풀이하여 이차 생성물(13.2g, 15%, 전체수율 95%)을 수득하였다.65.O1 g (0.116 mol) of 5-amino-2,4,6-triiodoisophthalic acid obtained in Example 2 was dispersed in 420 ml of ethyl acetate. 55.2 g (0.46 mol) of thionyl chloride was slowly added to the dispersion, and the resulting mixture was heated to reflux for 3-4 hours and then cooled to room temperature. Excess thionyl chloride and solvent were removed by distillation, and 135 ml of ethyl acetate was added to the distillation residue, followed by distillation under reduced pressure to completely remove volatile components. 940 ml of ethyl acetate was added to the evaporated residue, followed by dissolution. The mixture was washed with 1.12 L of saturated aqueous sodium bicarbonate solution and then with 0.6 L of saturated aqueous sodium bicarbonate solution, and then the organic layer was separated. The separated organic layer was dried over 200 g of anhydrous potassium carbonate-anhydrous magnesium sulfate (1: 1, w / w) mixed desiccant and filtered to obtain a clear filtrate. The solvent in the filtrate was crystallized while slowly evaporating under reduced pressure (730 mmHg), then filtered and the obtained crystals were washed with about 20 g of n-hexane. Vacuum drying at 50 ° C. gave the primary product (52.4 g, 80% yield). The procedure was repeated again for the filtrate obtained in the previous step to give a secondary product (13.2 g, 15%, 95% overall yield).

13C NMR(75㎒, CDCl3) δ 168.5, 150.5, 149.2, 84.9, 79.1 13 C NMR (75 MHz, CDCl 3 ) δ 168.5, 150.5, 149.2, 84.9, 79.1

[실시예 4] 0-아세틸-(S)-락트산클로라이드의 합성Example 4 Synthesis of 0-Acetyl- (S) -Lactic Acid Chloride

92%-(S)-락트산 수용액 295g(3.Omol)에 톨루엔 900㎖를 가하고 85~88℃, 진공하에서 공비로 물을 제거하였다. 이 용액에 아세트산 1000㎖와 촉매량의 진한 황산(98%-H2SO4, 0.7g)올 넣고 가열하여 90℃ 정도 되었을 때, 아세트산무수물 617g(6.O5mol)을 1시간에 걸쳐 가하고 가열하여 반응물의 온도를 105℃까지 상승시켰다. 계속하여 7시간을 완만히 환류시키면 116℃에 이르게 된다. 아세트산을 감압증류하여 제거하고, 생성된 0-아세틸-(S)-락트산에 DMF(0.28g)를 가하고 60℃ 까지 가열하였다. 여기에 티오닐클로라이드 395g(3.3mol)을 2시간에 걸쳐 적하하면 70℃에 도달하게 되고, 그 후에도 3시간 더 가열하였다. 과잉의 티오닐클로라이드를 60℃에서 감압증류하여 제거함으로써 무색투명한 표제화합물 430.1g(수율 80%)을 수득하였다.Toluene 900ml was added to 295g (3.Omol) of 92%-(S) -lactic-acid aqueous solution, and water was removed by azeotropy at 85-88 degreeC and vacuum. 1000 ml of acetic acid and a catalytic amount of concentrated sulfuric acid (98% -H 2 SO 4 , 0.7g) ol were added to the solution and heated to about 90 ° C. 617 g (6.O5 mol) of acetic anhydride was added over 1 hour, followed by heating. The temperature of was raised to 105 ° C. Continuously refluxing for 7 hours leads to 116 ° C. Acetic acid was removed by distillation under reduced pressure, and DMF (0.28 g) was added to the resulting 0-acetyl- (S) -lactic acid and heated to 60 ° C. When 395 g (3.3 mol) of thionyl chlorides were dripped here over 2 hours, it reached 70 degreeC, and further heated for 3 hours after that. Excess thionyl chloride was removed by distillation under reduced pressure at 60 DEG C to give 430.1 g (80% yield) of the title compound as a colorless transparent.

1H-NMR(300㎒, CDCl3) δ 5.11 (q, J=7.2㎐, 1H), 2.09(s, 3H), 1.54(d, J=7.2㎐, 3H); 1 H-NMR (300 MHz, CDCl 3 ) δ 5.11 (q, J = 7.2 μs, 1H), 2.09 (s, 3H), 1.54 (d, J = 7.2 μs, 3H);

13C NMR(75㎒, CDCl3) δ 172.6, 169.7, 74.8, 20.4, 15.9 13 C NMR (75 MHz, CDCl 3 ) δ 172.6, 169.7, 74.8, 20.4, 15.9

[실시예 5] 5-[(0-아세틸)-(S)-락타미도]-2,4,6-트리요오도이소프탈산클로라이드의 합성Example 5 Synthesis of 5-[(0-acetyl)-(S) -lactamido] -2,4,6-triiodoisophthalic acid chloride

실시예 3에서 수득한 5-아미노-2,4,6-트리요오도이소프탈산클로라이드 40.Og(0.067mol)에 무수 DMA 4Og을 가하여 용해시킨후 빙욕에서 냉각시켰다. 생성된 혼합액을 교반하면서 실시예 4에서 수득한, 톨루엔에 용해되어 있는 0-아세틸-(S)-락트산클로라이드 40.96g(0.27mol)를 4시간에 걸쳐 천천히 적하하고 10시간 정도 더 반응시켰다. 얼음물(1ℓ)을 격렬히 교반하면서 위 반응혼합물올 천천히 적하하여 흰색의 분산액을 제조하고, 이 분산액을 약 15분 동안 더 교반하였다. 흰색의 고체를 여과하여 2O㎖의 아세토니트릴과 함께 교반하여 다시 분산액을 제조하였다. 흰 고체 생성물을 다시 여과하고 톨루엔(2O㎖×2)으로 세척한 다음 공기건조시키고 50℃에서 진공건조시켜 표제화합물 45.22g(수율 95%)을 수득하였다.40.Og (0.067 mol) of 5-amino-2,4,6-triiodoisophthalic acid chloride obtained in Example 3 was dissolved by adding 40 g of anhydrous DMA and cooled in an ice bath. While stirring the resulting mixture, 40.96 g (0.27 mol) of 0-acetyl- (S) -lactic acid chloride dissolved in toluene obtained in Example 4 was slowly added dropwise over 4 hours and reacted for another 10 hours. While slowly stirring the ice water (1 L), the reaction mixture was slowly added dropwise to prepare a white dispersion, which was further stirred for about 15 minutes. The white solid was filtered and stirred with 20 ml of acetonitrile to prepare a dispersion. The white solid product was filtered again, washed with toluene (20 mL × 2), air dried and vacuum dried at 50 ° C. to give 45.22 g (95% yield) of the title compound.

1H-NMR(300㎒, (CD3)2CO) δ 9.51(bs, 1H), 5.38(q, J=6.9㎐, 1H), 2.15(s, 3H), 1.59(d, J=6.9㎐, 3H); 1 H-NMR (300 MHz, (CD 3 ) 2 CO) δ 9.51 (bs, 1H), 5.38 (q, J = 6.9 ㎐, 1H), 2.15 (s, 3H), 1.59 (d, J = 6.9 ㎐ , 3H);

13C NMR(75㎒, (CD3)2CO) δ 170.0, 169.5, 169.4, 151.7, 145.5, 98.2, 83.0, 70.7, 20.9, 17.9 13 C NMR (75 MHz, (CD 3 ) 2 CO) δ 170.0, 169.5, 169.4, 151.7, 145.5, 98.2, 83.0, 70.7, 20.9, 17.9

[실시예 6] N,N'-비스[2-하이드록시-1-(하이드록시메틸)에틸]-2,4,6-트리요오도-5-(0-아세틸-(S)-락타미도)이소프탈아미드의 합성Example 6 N, N'-bis [2-hydroxy-1- (hydroxymethyl) ethyl] -2,4,6-triiodo-5- (0-acetyl- (S) -lactamido Synthesis of Isophthalamide

빛을 차단한 상태의 질소대기하에서 세리놀 4.Og(0.044 mol)을 DMA 28g에 용해시키고 이 용액에 2,6-루티딘 5.8g(0.054mol)을 가하였다. 이 교반용액에 실시예 5에서 수득한 5-[(0-아세틸)-(S)-락타미도]-2,4,6-트리요오도이소프탈산클로라이드 12.52g(0.O18몰)을 DMA 65g에 녹인 용액을 4시간에 걸쳐 상온에서 천천히 적하하고, 혼합액을 20시간정도 더 반응시켰다. 반응 혼합물중에 생성된 염을 여과하고 5g의 DMA(디메틸아세트아미드)로 세척하였다. 여액을 진공하에 증류시키고, 잔류된 고형물에 아세톤 100g을 가하여 결정화시켰다. 생성된 백색의 고체를 여과하고 약 1Og의 아세톤으로 세척한 후 감압건조시켜 백색분말의 표제화합물 17.3g(수율 100%, 분석결과 순도 83%)을 수득하였다.Under nitrogen atmosphere with light blocking, 4.Og (0.044 mol) of cerinol was dissolved in 28 g of DMA and 5.8 g (0.054 mol) of 2,6-lutidine was added to the solution. Into this stirred solution, 12.52 g (0.18 mol) of 5-[(0-acetyl)-(S) -lactamido] -2,4,6-triiodoisophthalic acid chloride obtained in Example 5 was added to 65 g of DMA. The solution dissolved in was slowly added dropwise at room temperature over 4 hours, and the mixed solution was further reacted for about 20 hours. The resulting salt in the reaction mixture was filtered and washed with 5 g of DMA (dimethylacetamide). The filtrate was distilled under vacuum and crystallized by adding 100 g of acetone to the remaining solid. The resulting white solid was filtered, washed with about 10 g of acetone, and dried under reduced pressure to obtain 17.3 g (yield 100%, purity 83%) of the title compound as a white powder.

1H-NMR(300㎒, D20) δ 5.35(q, J=6.9㎐, 1H), 4.17(q, J=5.1㎐, 2H), 3.83 (bd, J=5.1㎐, 8H), 2.23(s, 3H), 1.71(d, J=6.9㎐, 3H); 1 H-NMR (300 MHz, D 2 0) δ 5.35 (q, J = 6.9 Hz, 1H), 4.17 (q, J = 5.1 Hz, 2H), 3.83 (bd, J = 5.1 Hz, 8H), 2.23 (s, 3H), 1.71 (d, J = 6.9 Hz, 3H);

13C NMR(75㎒, D20) δ 174.7, 173.41 및 173.21, 172.65 및 172.56 및 172.48, 150.0, 142.3, 98.39 및 98.29, 89.9, 71.7, 59.3, 54.80 및 54.59, 21.O5 17.8; 13 C NMR (75 MHz, D 2 0) δ 174.7, 173.41 and 173.21, 172.65 and 172.56 and 172.48, 150.0, 142.3, 98.39 and 98.29, 89.9, 71.7, 59.3, 54.80 and 54.59, 21.O5 17.8;

[실시예 7] N,N'-비스[2-하이드록시-1-(하이드록시메틸)에틸]-2,4,6-트리요오도-5-락타미드이소프탈아미드(이오파미돌)의 합성Example 7 of N, N'-bis [2-hydroxy-1- (hydroxymethyl) ethyl] -2,4,6-triiodo-5-lactamide isophthalamide (iofamido) synthesis

수산화칼슘 1.31g(93% assay, 0.022mol)을 물 8Og에 용해시켜 백색 현탁액을 제조하고, 여기에 실시예 6에서 수득한 N,N'-비스[2-하이드록시-1-(하이드록시메틸)에틸]-2,4,6-트리요오도-5-(0-아세틸-(S)락타미도)이소프탈아미드 19.67g(83% 순도, 0.02Omol)을 녹여 약 30℃에서 가열 교반하여 반응을 진행시켰다. 내용물을 TLC와 HPLC로 분석하여 출발물이 없어질 때까지 반응시켰다. 반응이 종결된 반응물에 진한황산 2.5g(0.O24mol)을 서서히 가하여 생성된 고체를 약 1시간동안 교반한 후 여과하여 물 6Oℓ 씩 2회 세척하였다. 여액에 1N 옥살산 용액 1O㎖(5.Ommol)을 사용하여 pH 1.1±0.1로 유지하면서 10시간 이상 정치시킨 후 분말활성탄 1g을 가하고 1시간동안 교반하였다. 반응혼합물을 여과하고 물 3O㎖로 세척하였다. 여액을 양이온수지칼럼(수지량 5O㎖)과 음이온수지칼럼(수지량 100㎖)에 통과시킨 후, HP-2O 탈색수지를 통과시켜 무색투명한 용액을 수득하였다. 이 무색 투명한 전개용액을 45-50℃에서 감압증류하여 물을 완전히 제거하여 유리상의 고체를 수득하였다. 고체 생성물을 에탄올에서 재결정한 후 건조시켜 백색의 결정성 이오파미돌 16.23g(95%)을 수득하였다.Dissolve 1.31 g (93% assay, 0.022 mol) of calcium hydroxide in 80 g of water to prepare a white suspension, wherein the N, N'-bis [2-hydroxy-1- (hydroxymethyl) obtained in Example 6 was obtained. Ethyl] -2,4,6-triiodo-5- (0-acetyl- (S) lactamido) isophthalamide 19.67g (83% purity, 0.02Omol) was dissolved in the reaction by heating and stirring at about 30 ℃ Proceeded. The contents were analyzed by TLC and HPLC and reacted until the start was gone. 2.5 g (0.24 mol) of concentrated sulfuric acid was slowly added to the reaction mixture, and the resulting solid was stirred for about 1 hour, and then filtered and washed twice with 600 L of water. 1N oxalic acid solution (10.Ommol) was added to the filtrate and maintained at pH 1.1 ± 0.1 for 10 hours or longer. Then, 1 g of powdered activated carbon was added and stirred for 1 hour. The reaction mixture was filtered and washed with 30 ml of water. The filtrate was passed through a cationic resin column (50 ml of resin) and an anion resin column (100 ml of resin), followed by HP-2O decolorizing resin to obtain a colorless transparent solution. This colorless transparent developing solution was distilled under reduced pressure at 45-50 ° C. to completely remove water to obtain a glassy solid. The solid product was recrystallized in ethanol and dried to give 16.23 g (95%) of white crystalline iopamidol.

1H-NMR(300㎒, D20) δ 4.33(q, J=6.9㎐, 1H), 3.984(quintet, J=5.3㎐, 2H), 3.66(bd, J=5.3㎐, 8H), 1.40(d, J=6.9㎐, 3H); 1 H-NMR (300 MHz, D 2 0) δ 4.33 (q, J = 6.9 Hz, 1H), 3.984 (quintet, J = 5.3 Hz, 2H), 3.66 (bd, J = 5.3 Hz, 8H), 1.40 (d, J = 6.9 Hz, 3H);

13C-NMR(75㎒, D20) δ 177.56 및 177.34, 172.60 및 172.55 및 172.45, 149.95 및 149.88, 142.9, 98.82 및 98.71, 89.9, 68.9, 60.6, 53.92 및 53.85, 20.41 13 C-NMR (75 MHz, D 2 0) δ 177.56 and 177.34, 172.60 and 172.55 and 172.45, 149.95 and 149.88, 142.9, 98.82 and 98.71, 89.9, 68.9, 60.6, 53.92 and 53.85, 20.41

상기 설명한 바와 같은 본 발명의 제조방법에 따르면 X-ray 조영제로서 많이 사용되고 있는 이오파미돌이 효과적으로 제조될 수 있다.According to the manufacturing method of the present invention as described above, iopamidol, which is widely used as an X-ray contrast agent, can be effectively produced.

Claims (6)

하기 반응식 1에 따라 화학식 1의 이오파미돌을 제조함에 있어서, 화학식 6의 5-아미노이소프탈산과 KIC12를 반응시키는 공정 1을 5-아미노이소프탈산 대비 1 내지 5중량%의 요오드 존재하에 수행하고 공정 3에서는 락트산에 톨루엔을 가하여 공비증류로 물을 제거한 다음 아세트산무수물과 초산 및 티오닐클로라이드를 반응시켜 제조된 0-아세틸락트산클로라이드 톨루엔 용액과 화학식 4의 5-아미노-2,4,6-트리요오도이소프탈산클로라이드를 반응시킴을 특징으로 하는 방법.In preparing the iopamidol of Chemical Formula 1 according to Scheme 1, Process 1 of reacting 5-aminoisophthalic acid of Chemical Formula 6 with KIC1 2 was carried out in the presence of 1 to 5% by weight of iodine relative to 5-aminoisophthalic acid. In step 3, toluene is added to lactic acid to remove water by azeotropic distillation, and then a solution of 0-acetyl lactic acid chloride toluene prepared by acetic anhydride, acetic acid and thionyl chloride, and 5-amino-2,4,6-tri represented by the formula (4) Characterized by reacting iodoisophthalic acid chloride. [반응식 1]Scheme 1 제1항에 있어서, 최소한의 티오닐클로라이드와 에틸아세테이트 용매를 사용하여 공정 2를 수행함을 특징으로 하는 방법.The process of claim 1 wherein process 2 is carried out using a minimum of thionylchloride and ethyl acetate solvent. 제1항 또는 제2항에 있어서, 락트산으로부터 제조된 0-아세틸락트산클로라이드를 분리정제하지않고 바로 공정 3의 반응에 사용함을 특징으로 하는 방법.The process according to claim 1 or 2, characterized in that 0-acetyllactic acid chloride prepared from lactic acid is used directly in the reaction of Step 3 without separating and purification. 제1항 또는 제2항에 있어서, 공정 3에서 0-아세틸락트산클로라이드를 화학식 4의 5-아미노-2,4,6-트리요오도이소프탈산클로라이드에 대해 1.5 내지 1.8 당량배로 사용함을 특징으로 하는 방법.The process according to claim 1 or 2, characterized in that in step 3 0-acetyllactic acid chloride is used at 1.5 to 1.8 equivalent times of 5-amino-2,4,6-triiodoisophthalic acid chloride of the formula (4). Way. 제1항 또는 제2항에 있어서, 공정 4에서 염기로 2,6-루티딘을 사용함을 특징으로 하는 방법.The process according to claim 1 or 2, characterized in that in step 4 2,6-lutidine is used as the base. 제1항 또는 제2항에 있어서, 공정 5에서 양이온 및 음이온교환수지를 이용하여 불순물을 제거하고 에탄올을 사용하여 이오파미돌을 재결정함을 특징으로 하는 방법.The process according to claim 1 or 2, wherein in step 5, impurities are removed using cation and anion exchange resin and recrystallized iopamidol using ethanol.
KR1019980022514A 1998-06-16 1998-06-16 Manufacturing method of Iopamidol KR100294621B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019980022514A KR100294621B1 (en) 1998-06-16 1998-06-16 Manufacturing method of Iopamidol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980022514A KR100294621B1 (en) 1998-06-16 1998-06-16 Manufacturing method of Iopamidol

Publications (2)

Publication Number Publication Date
KR20000001987A KR20000001987A (en) 2000-01-15
KR100294621B1 true KR100294621B1 (en) 2001-11-26

Family

ID=19539622

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980022514A KR100294621B1 (en) 1998-06-16 1998-06-16 Manufacturing method of Iopamidol

Country Status (1)

Country Link
KR (1) KR100294621B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT105770B (en) * 2011-06-24 2013-07-08 Hovione Farmaciencia S A NEW INTERMEDIARY AND ITS USE IN THE PREPARATION OF CONTRACT TRIUMPHENT AGENT
PT108524B (en) * 2015-06-02 2017-12-15 Hovione Farmaciência S A PROCESS FOR THE PREPARATION OF USEFUL INTERMEDIARIES IN THE PREPARATION OF NON-IONIC CONTRACTING AGENTS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2271990A (en) * 1992-10-27 1994-05-04 Zambon Spa Process for the preparation of L-5-(2-acetoxy-propionyl-amino)-2,4,6-triiodo- isophthalic acid dichloride

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2271990A (en) * 1992-10-27 1994-05-04 Zambon Spa Process for the preparation of L-5-(2-acetoxy-propionyl-amino)-2,4,6-triiodo- isophthalic acid dichloride

Also Published As

Publication number Publication date
KR20000001987A (en) 2000-01-15

Similar Documents

Publication Publication Date Title
CA2361716C (en) Method of preparing alkylated salicylamides
JP5156862B2 (en) A novel process for the production of iopromide
JP5536087B2 (en) Method for producing iodinated contrast agent
JP2010229157A (en) Method for preparing r-(-)-carnitine from s-(-)-chlorosuccinic acid or derivative thereof
KR101888392B1 (en) Manufacture of a triiodinated contrast agent
KR100294621B1 (en) Manufacturing method of Iopamidol
KR100286639B1 (en) Process for preparing iopromide
KR20010071221A (en) Process for the preparation of S-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy -1-oxopropyl)-amino]-2,4,6-triiodo-1,3-benzendicarboxamide
US5728877A (en) Process for the manufacturing of iodinated contrast agents
EP0182279A1 (en) Process for the optical resolution of racemic mixtures of alpha-naphtyl-propionic acids
JP4278859B2 (en) Method for producing oxaazaphosphorin-2-amine
JP4035198B2 (en) Process for producing intermediates useful for the synthesis of iodinated contrast agents
JP3979743B2 (en) Method for producing optically active vinyl phosphine oxide
JP3640319B2 (en) Method for producing benzamide derivative
JP4551514B2 (en) Process for producing unsaturated hydrocarbon residue-substituted anilines
EP0853077B1 (en) Process for producing alkyl 3-amino-4-substituted benzoates
SK287134B6 (en) Process for production of (R) and (S)-carnitine and their intermediate products
JP2765696B2 (en) Method for producing 5-amino-2,4,6-triiodoisophthalic acid
HU207709B (en) Process for producing n-/n-propyl/-n-/2-/2,4,6-trichloro-phenoxy/-ethyl/-amine
JPH0632768A (en) Production of unsaturated quaternary ammonium salt
JPS6056942A (en) Optically active n-methylephedrine ester of 2,2- dimethylcyclopropanecarboxylic acid and salt thereof
US20030109737A1 (en) Process for the preparation of oxazaphosphorine-2-amines
JP3669726B2 (en) Process for producing optically active 3- (p-alkoxyphenyl) glycidic acid ester derivative
JPS6317869A (en) Production of 2-lower alkyl-4-amino-5-formylpyrimidine
JP2004059492A (en) Method for producing optically active alpha-(2-aminophenyl)benzylamine

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050328

Year of fee payment: 5

EXTG Extinguishment